Sunesis Pharmaceuticals, Inc. announced earnings results for the second quarter ended June 30, 2020. For the second quarter, the company announced operating loss was USD 6.345 million compared to USD 6.206 million a year ago. Net loss was USD 6.390 million compared to USD 6.241 million a year ago. Basic loss per share from continuing operations was USD 0.06 compared to USD 0.09 a year ago. For the half year, operating loss was USD 12.143 million compared to USD 11.893 million a year ago. Net loss was USD 12.165 million compared to USD 12.101 million a year ago. Basic loss per share from continuing operations was USD 0.11 compared to USD 0.18 a year ago.